Abdominal Neoplasms - 350 Studies Found
| Completed |
: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer :
|
| Terminated |
: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer :
|
| Completed |
: A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer :
|
| Completed |
: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer :
|
| Completed |
: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer :
|
| Completed |
: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer :
|
| Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer :
: |
| Completed |
: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer :
|
| Completed |
: Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer :
|
| Completed |
: Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer :
: 2005-09-20 :
|